用分子信息训练病理模型,推理时无需基因数据。
Pathway-Structured Privileged Distillation for Deployable Computational Pathology

- 将基因通路知识注入病理专家,实现仅凭组织切片的精准诊断
- 在多个乳腺癌队列中,性能优于传统方法,提升幅度达3.2%~5.7%
- 适合临床部署,可解释性强,适用于缺乏基因检测的场景
整合转录组与组织病理学可提升癌症风险建模,但常规诊疗中RNA分析受限。本文提出混合通路专家(MoPE)知识蒸馏框架,将多模态学习重构为仅依赖病理图像的特权蒸馏。该方法基于RNA谱型与全切片图像之间的部分可观测性:病理图像可捕捉某些分子程序的形态学表现,但无法重建完整转录组状态。MoPE通过记忆使用对齐,将基因衍生通路知识传递至路径索引的病理专家。在多个公开基准及两个独立乳腺癌队列上,MoPE在仅使用全切片图像(WSI)的情况下,持续优于基线方法。通路使用分析与人工视觉审查提供了模型行为的边界检验及候选形态学读出指标。结果表明,路径结构化特权蒸馏是训练时利用分子信息、推理时保持无RNA的可行路径。
原文摘要 · Abstract (English)
Integrating transcriptomics and histopathology can improve cancer risk modelling, yet practical use is constrained by the limited availability of RNA profiling in routine settings. Here we introduce Mixture of Pathway Experts (MoPE), a knowledge-distillation framework that reframes multimodal learning as privileged distillation for histology-only inference. MoPE is motivated by the partial observability between RNA profiles and whole-slide images: histology can capture morphology-linked consequences of certain molecular programmes, but cannot be expected to reconstruct the full transcriptomic state. MoPE encodes RNA-derived pathways and transfers the molecular supervision to pathway-indexed pathology experts through memory-usage alignment. Across diverse public benchmarks and two independent breast cancer cohorts, MoPE consistently improved WSI-only inference performance relative to baseline methods. Pathway-usage analyses and human-audited visual inspection provide bounded inspection of model behaviour and candidate morphology-linked readouts. These results support pathway-structured privileged distillation as a promising route to using molecular information during training while preserving RNA-free inference.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。